Oneness Biotech Co., Ltd. (LUX: ONES)
Luxembourg
· Delayed Price · Currency is EUR · Price in USD
12.10
0.00 (0.00%)
At close: Jan 22, 2025
Oneness Biotech Revenue
Oneness Biotech had revenue of 29.30M TWD in the quarter ending September 30, 2024, with 53.97% growth. This brings the company's revenue in the last twelve months to 112.20M, up 47.85% year-over-year. In the year 2023, Oneness Biotech had annual revenue of 86.78M, down -91.86%.
Revenue (ttm)
112.20M TWD
Revenue Growth
+47.85%
P/S Ratio
n/a
Revenue / Employee
2.61M TWD
Employees
43
Market Cap
1.04B EUR
Revenue Chart
* This company reports financials in TWD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
Dec 31, 2020 | 41.61M | 28.13M | 208.76% |
Dec 31, 2019 | 13.48M | -5.38M | -28.54% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reinet Investments S.C.A. | 1.04B |
Luxempart | 133.77M |
CPI FIM | 78.44M |
Socfinasia | 178.94M |
Socfinaf | 550.77M |
GP Investments | 96.12M |
Velcan Holdings | 3.01M |